mTOR Inhibitors

All categories
DBCAT004158Pharmacologic class

Medications that exert their immunosuppressive effects via inhibition of the mammalian target of rapamycin (mTOR). A DrugBank category of 10 drugs. 5 of them are approved.

Drugs

What you can answer from here — as of December 12, 2019

10DrugsEach linked to its full drug card
Listed above
6Drug targetsEvery drug–target pair in the class, with bond type
Sign in
581Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
5Routes of administrationHow the drugs in this class are given
Sign in

Which targets do mTOR Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In